My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 962

    1.

    Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.

    Kovacs P, Geyer M, Berndt J, Klöting N, Graham TE, Böttcher Y, Enigk B, Tönjes A, Schleinitz D, Schön MR, Kahn BB, Blüher M, Stumvoll M.

    Diabetes. 2007 Dec;56(12):3095-100. Epub 2007 Aug 29.PMID: 17728376 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population.

    Hu C, Jia W, Zhang R, Wang C, Lu J, Wu H, Fang Q, Ma X, Xiang K.

    Diabet Med. 2008 Jan;25(1):11-8.PMID: 18199128 [PubMed - indexed for MEDLINE]Related articles

    3.

    Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.

    Böttcher Y, Teupser D, Enigk B, Berndt J, Klöting N, Schön MR, Thiery J, Blüher M, Stumvoll M, Kovacs P.

    J Clin Endocrinol Metab. 2006 Jul;91(7):2725-31. Epub 2006 Apr 24.PMID: 16636125 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits.

    Craig RL, Chu WS, Elbein SC.

    Mol Genet Metab. 2007 Mar;90(3):338-44. Epub 2006 Dec 14.PMID: 17174134 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

    Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Häring HU.

    Diabetes Care. 2007 May;30(5):1173-8. Epub 2007 Jan 26.PMID: 17259477 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.

    Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2590-7. Epub 2007 Jun 26.PMID: 17595259 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.

    Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA, Tripathy D.

    Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E758-64. Epub 2009 Feb 3.PMID: 19190263 [PubMed - indexed for MEDLINE]Related articles

    8.

    Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity.

    Bajzová M, Kováciková M, Vítková M, Klimcáková E, Polák J, Kovácová Z, Viguerie N, Vedral T, Mikulásek L, Srámková P, Srp A, Hejnová J, Langin D, Stich V.

    Physiol Res. 2008;57(6):927-34. Epub 2007 Nov 30.PMID: 18052678 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia.

    Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, Kumada M, Erdenebulgan B, Zolzaya K, Lkhagvasuren T, Iwamoto S.

    Hum Genet. 2007 Feb;120(6):879-88. Epub 2006 Sep 28.PMID: 17006670 [PubMed - indexed for MEDLINE]Related articles

    10.

    Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

    Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB.

    N Engl J Med. 2006 Jun 15;354(24):2552-63.PMID: 16775236 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

    Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS.

    Diabetes Care. 2006 Nov;29(11):2457-61.PMID: 17065684 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.

    Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K.

    J Clin Endocrinol Metab. 2007 Aug;92(8):3224-9. Epub 2007 Jun 5.PMID: 17550959 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity.

    Böttcher Y, Unbehauen H, Klöting N, Ruschke K, Körner A, Schleinitz D, Tönjes A, Enigk B, Wolf S, Dietrich K, Koriath M, Scholz GH, Tseng YH, Dietrich A, Schön MR, Kiess W, Stumvoll M, Blüher M, Kovacs P.

    Diabetes. 2009 Sep;58(9):2119-28. Epub 2009 Jun 5.PMID: 19502417 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.

    Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA.

    J Clin Endocrinol Metab. 2007 May;92(5):1886-90. Epub 2007 Feb 13.PMID: 17299074 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.

    Klöting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schön MR, Stumvoll M, Blüher M, Kahn BB.

    Cell Metab. 2007 Jul;6(1):79-87.PMID: 17618858 [PubMed - indexed for MEDLINE]Related articles

    16.

    Variants in the Ca V 2.3 (alpha 1E) subunit of voltage-activated Ca2+ channels are associated with insulin resistance and type 2 diabetes in Pima Indians.

    Muller YL, Hanson RL, Zimmerman C, Harper I, Sutherland J, Kobes S; International Type 2 Diabetes 1q Consortium, Knowler WC, Bogardus C, Baier LJ.

    Diabetes. 2007 Dec;56(12):3089-94. Epub 2007 Aug 24.PMID: 17720895 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.

    Staiger H, Stancáková A, Zilinskaite J, Vänttinen M, Hansen T, Marini MA, Hammarstedt A, Jansson PA, Sesti G, Smith U, Pedersen O, Laakso M, Stefan N, Fritsche A, Häring HU.

    Diabetes. 2008 Feb;57(2):514-7. Epub 2007 Nov 26.PMID: 18039816 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.

    Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V, Doria A.

    Diabetes. 2002 Jul;51(7):2306-12.PMID: 12086965 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects.

    Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, Tassi V, Lauro R, Perticone F, Sesti G.

    Diabetes. 2006 May;55(5):1529-33.PMID: 16644716 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action.

    Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P.

    Diabetes. 2009 Jan;58(1):54-60. Epub 2008 Oct 13.PMID: 18852328 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity